Seeking men and women 18 years of age to 65 years of age who self identify as African American and/or Hispanic/Latino American, with relapsing multiple sclerosis to study an investigational, intravenous drug.
We are studying the safety and efficacy of an investigational drug on relapsing multiple sclerosis (RMS) in participants who self identify as African American and/or Hispanic/Latino American.
What we're hoping for
We hope to evaluate disease activity during treatment with the investigational drug in minority patients with relapsing multiple sclerosis (RMS).
ClinicalTrials.gov Identifier: NCT04377555